Firststring Research, Inc.
Records under this name other than patents Firststring Research, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Firststring Research, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,161,984 | Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,632,173 | Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,524,049 | Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,128,086 | Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,138,293 | Peptide Formulations and Ophthalmic Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,846,605 | Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides Formerly held Lapsed on the fee record Ended Sep 30, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 30, 2026 | Medium confidence |